IBDEI1RM ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31562,2)
 ;;=^5015630
 ;;^UTILITY(U,$J,358.3,31563,0)
 ;;=N30.01^^190^1939^18
 ;;^UTILITY(U,$J,358.3,31563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31563,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Acute
 ;;^UTILITY(U,$J,358.3,31563,1,4,0)
 ;;=4^N30.01
 ;;^UTILITY(U,$J,358.3,31563,2)
 ;;=^5015633
 ;;^UTILITY(U,$J,358.3,31564,0)
 ;;=N30.00^^190^1939^20
 ;;^UTILITY(U,$J,358.3,31564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31564,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Acute
 ;;^UTILITY(U,$J,358.3,31564,1,4,0)
 ;;=4^N30.00
 ;;^UTILITY(U,$J,358.3,31564,2)
 ;;=^5015632
 ;;^UTILITY(U,$J,358.3,31565,0)
 ;;=N30.41^^190^1939^19
 ;;^UTILITY(U,$J,358.3,31565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31565,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Irradiation
 ;;^UTILITY(U,$J,358.3,31565,1,4,0)
 ;;=4^N30.41
 ;;^UTILITY(U,$J,358.3,31565,2)
 ;;=^5015640
 ;;^UTILITY(U,$J,358.3,31566,0)
 ;;=N30.40^^190^1939^21
 ;;^UTILITY(U,$J,358.3,31566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31566,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Irradiation
 ;;^UTILITY(U,$J,358.3,31566,1,4,0)
 ;;=4^N30.40
 ;;^UTILITY(U,$J,358.3,31566,2)
 ;;=^5015639
 ;;^UTILITY(U,$J,358.3,31567,0)
 ;;=N32.0^^190^1939^6
 ;;^UTILITY(U,$J,358.3,31567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31567,1,3,0)
 ;;=3^Bladder-Neck Obstruction
 ;;^UTILITY(U,$J,358.3,31567,1,4,0)
 ;;=4^N32.0
 ;;^UTILITY(U,$J,358.3,31567,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,31568,0)
 ;;=N31.9^^190^1939^69
 ;;^UTILITY(U,$J,358.3,31568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31568,1,3,0)
 ;;=3^Neuromuscular Dysfunction of Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,31568,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,31568,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,31569,0)
 ;;=N31.1^^190^1939^70
 ;;^UTILITY(U,$J,358.3,31569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31569,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,31569,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,31569,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,31570,0)
 ;;=N32.89^^190^1939^5
 ;;^UTILITY(U,$J,358.3,31570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31570,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,31570,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,31570,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,31571,0)
 ;;=N33.^^190^1939^4
 ;;^UTILITY(U,$J,358.3,31571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31571,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,31571,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,31571,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,31572,0)
 ;;=N34.2^^190^1939^95
 ;;^UTILITY(U,$J,358.3,31572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31572,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,31572,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,31572,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,31573,0)
 ;;=N34.1^^190^1939^96
 ;;^UTILITY(U,$J,358.3,31573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31573,1,3,0)
 ;;=3^Urethritis,Nonspec
 ;;^UTILITY(U,$J,358.3,31573,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,31573,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,31574,0)
 ;;=N39.0^^190^1939^99
 ;;^UTILITY(U,$J,358.3,31574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31574,1,3,0)
 ;;=3^Urinary Tract Infection,Site Not Spec
 ;;^UTILITY(U,$J,358.3,31574,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,31574,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,31575,0)
 ;;=N31.0^^190^1939^71
 ;;^UTILITY(U,$J,358.3,31575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31575,1,3,0)
 ;;=3^Neuropathic Bladder,Uninhibited NEC
 ;;^UTILITY(U,$J,358.3,31575,1,4,0)
 ;;=4^N31.0
 ;;^UTILITY(U,$J,358.3,31575,2)
 ;;=^5015644
